WallStreetZenWallStreetZen

NASDAQ: VKTX
Viking Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for VKTX

Based on 8 analysts offering 12 month price targets for Viking Therapeutics Inc.
Min Forecast
$80.00+23.21%
Avg Forecast
$112.25+72.88%
Max Forecast
$138.00+112.54%

Should I buy or sell VKTX stock?

Based on 8 analysts offering ratings for Viking Therapeutics Inc.
Strong Buy
Strong Buy
5 analysts 62.5%
Buy
3 analysts 37.5%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VKTX stock forecasts and price targets.

VKTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-27Find Out Why
lockedlocked$00.00+00.00%2024-03-26Find Out Why
lockedlocked$00.00+00.00%2024-03-26
lockedlocked$00.00+00.00%2024-03-15Find Out Why
lockedlocked$00.00+00.00%2024-03-15
Jefferies
Bottom 5%
5
Strong BuyInitiates Coverage On$110.00+69.41%2024-03-07Find out why
Truist Securities
Top 7%
94
Strong BuyMaintains$120.00+84.81%2024-02-29Find out why
Raymond James
Top 11%
90
BuyMaintains$115.00+77.11%2024-02-27Find out why

1 of 1

Forecast return on equity

Is VKTX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.5%

Forecast return on assets

Is VKTX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

VKTX revenue forecast

What is VKTX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$78.1M
Avg 2 year Forecast
$69.7M
Avg 3 year Forecast
$300.8M

VKTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VKTX$64.93$112.25+72.88%Strong Buy
PCVX$60.88$96.00+57.69%Strong Buy
CYTK$65.57$87.36+33.24%Strong Buy
JAZZ$109.67$193.09+76.07%Strong Buy
IONS$41.84$56.78+35.70%Buy

Viking Therapeutics Stock Forecast FAQ

Is Viking Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: VKTX) stock is to Strong Buy VKTX stock.

Out of 8 analysts, 5 (62.5%) are recommending VKTX as a Strong Buy, 3 (37.5%) are recommending VKTX as a Buy, 0 (0%) are recommending VKTX as a Hold, 0 (0%) are recommending VKTX as a Sell, and 0 (0%) are recommending VKTX as a Strong Sell.

If you're new to stock investing, here's how to buy Viking Therapeutics stock.

What is VKTX's revenue growth forecast for 2026-2028?

(NASDAQ: VKTX) Viking Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.16%.

Viking Therapeutics's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast VKTX's revenue for 2026 to be $7,852,158,809, with the lowest VKTX revenue forecast at $7,852,158,809, and the highest VKTX revenue forecast at $7,852,158,809. On average, 2 Wall Street analysts forecast VKTX's revenue for 2027 to be $7,008,056,762, with the lowest VKTX revenue forecast at $6,631,225,491, and the highest VKTX revenue forecast at $7,384,888,033.

In 2028, VKTX is forecast to generate $30,228,098,231 in revenue, with the lowest revenue forecast at $5,918,763,167 and the highest revenue forecast at $55,298,732,952.

What is VKTX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: VKTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is VKTX's Price Target?

According to 8 Wall Street analysts that have issued a 1 year VKTX price target, the average VKTX price target is $112.25, with the highest VKTX stock price forecast at $138.00 and the lowest VKTX stock price forecast at $80.00.

On average, Wall Street analysts predict that Viking Therapeutics's share price could reach $112.25 by Mar 27, 2025. The average Viking Therapeutics stock price prediction forecasts a potential upside of 72.88% from the current VKTX share price of $64.93.

What is VKTX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: VKTX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.